体外生命支持组织 2019 年冠状病毒病临时指南：来自体外膜氧合多学科提供者国际小组的共识文件。
Extracorporeal Life Support Organization Coronavirus Disease 2019 Interim Guidelines: A Consensus Document from an International Group of Interdisciplinary Extracorporeal Membrane Oxygenation Providers.
机构信息
From Adult Intensive Care Services, The Prince Charles Hospital, Brisbane, Queensland, Australia.
University of Washington, Seattle, Washington.
出版信息
ASAIO J. 2020 Jul;66(7):707-721. doi: 10.1097/MAT.0000000000001193.
Abstract
Disclaimer: The Extracorporeal Life Support Organization (ELSO) Coronavirus Disease 2019 (COVID-19) Guidelines have been developed to assist existing extracorporeal membrane oxygenation (ECMO) centers to prepare and plan provision of ECMO during the ongoing pandemic. The recommendations have been put together by a team of interdisciplinary ECMO providers from around the world. Recommendations are based on available evidence, existing best practice guidelines, ethical principles, and expert opinion. This is a living document and will be regularly updated when new information becomes available. ELSO is not liable for the accuracy or completeness of the information in this document. These guidelines are not meant to replace sound clinical judgment or specialist consultation but rather to strengthen provision and clinical management of ECMO specifically, in the context of the COVID-19 pandemic.
摘要
免责声明
体外生命支持组织（ELSO）的 2019 年冠状病毒病（COVID-19）指南旨在帮助现有的体外膜氧合（ECMO）中心在持续大流行期间准备和计划提供 ECMO。这些建议是由来自世界各地的跨学科 ECMO 提供者组成的团队共同制定的。建议基于现有证据、现有最佳实践指南、伦理原则和专家意见。这是一份实时文件，将在有新信息可用时定期更新。ELSO 不对本文件中信息的准确性或完整性负责。这些指南并非旨在取代合理的临床判断或专家咨询，而是旨在加强 COVID-19 大流行期间 ECMO 的提供和临床管理。
相似文献
1
Extracorporeal Life Support Organization Coronavirus Disease 2019 Interim Guidelines: A Consensus Document from an International Group of Interdisciplinary Extracorporeal Membrane Oxygenation Providers.体外生命支持组织 2019 年冠状病毒病临时指南：来自体外膜氧合多学科提供者国际小组的共识文件。
ASAIO J. 2020 Jul;66(7):707-721. doi: 10.1097/MAT.0000000000001193.
2
Regional extracorporeal membrane oxygenation retrieval service during the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic: an interdisciplinary team approach to maintain service provision despite increased demand.严重急性呼吸综合征冠状病毒 2（SARS-CoV-2）大流行期间的区域性体外膜肺氧合检索服务：尽管需求增加，但仍采用跨学科团队方法维持服务提供。
Eur J Cardiothorac Surg. 2020 Nov 1;58(5):875-880. doi: 10.1093/ejcts/ezaa327.
3
Extracorporeal Membrane Oxygenation (ECMO) in Critically Ill Patients with Coronavirus Disease 2019 (COVID-19) Pneumonia and Acute Respiratory Distress Syndrome (ARDS).体外膜肺氧合（ECMO）在 2019 冠状病毒病（COVID-19）肺炎和急性呼吸窘迫综合征（ARDS）危重症患者中的应用。
Med Sci Monit. 2020 Aug 6;26:e925364. doi: 10.12659/MSM.925364.
4
Regional Planning for Extracorporeal Membrane Oxygenation Allocation During Coronavirus Disease 2019.区域规划在 2019 冠状病毒病期间的体外膜肺氧合分配。
Chest. 2020 Aug;158(2):603-607. doi: 10.1016/j.chest.2020.04.026. Epub 2020 Apr 25.
5
Extracorporeal membrane oxygenation support in COVID-19: an international cohort study of the Extracorporeal Life Support Organization registry.COVID-19 患者的体外膜肺氧合支持：体外生命支持组织登记处的国际队列研究。
Lancet. 2020 Oct 10;396(10257):1071-1078. doi: 10.1016/S0140-6736(20)32008-0. Epub 2020 Sep 25.
6
Extracorporeal Membrane Oxygenation for Pediatric Patients With Coronavirus Disease 2019-Related Illness.体外膜肺氧合在儿童 2019 冠状病毒病相关疾病中的应用。
Pediatr Crit Care Med. 2020 Oct;21(10):893-897. doi: 10.1097/PCC.0000000000002432.
7
Extracorporeal membrane oxygenation (ECMO): does it have a role in the treatment of severe COVID-19?体外膜肺氧合（ECMO）：在治疗严重 COVID-19 中是否有作用？
Int J Infect Dis. 2020 May;94:78-80. doi: 10.1016/j.ijid.2020.03.058. Epub 2020 Apr 3.
8
Planning and provision of ECMO services for severe ARDS during the COVID-19 pandemic and other outbreaks of emerging infectious diseases.COVID-19 大流行期间和其他新发传染病疫情中严重急性呼吸窘迫综合征的体外膜肺氧合服务规划和供应。
Lancet Respir Med. 2020 May;8(5):518-526. doi: 10.1016/S2213-2600(20)30121-1. Epub 2020 Mar 20.
9
Veno-venous Extracorporeal Membrane Oxygenation Support in COVID-19 Respiratory Distress Syndrome: Initial Experience.COVID-19 呼吸窘迫综合征的静脉-静脉体外膜肺氧合支持：初步经验。
ASAIO J. 2020 Jul;66(7):734-738. doi: 10.1097/MAT.0000000000001198.
10
Optimizing provision of extracorporeal life support during the COVID-19 pandemic: practical considerations for Canadian jurisdictions.在2019冠状病毒病大流行期间优化体外生命支持的提供：加拿大各司法管辖区的实际考量
CMAJ. 2020 Apr 6;192(14):E372-E374. doi: 10.1503/cmaj.200448. Epub 2020 Mar 26.
引用本文的文献
1
The use of extracorporeal membrane oxygenation in COVID-19: a systematic review.体外膜肺氧合在新型冠状病毒肺炎中的应用：一项系统综述
Arch Med Sci. 2023 Jan 20;21(3):897-918. doi: 10.5114/aoms/152022. eCollection 2025.
2
Prolonged ECMO Management (124 Days) in a Severe COVID-19 Patient Complicated by Acute Myocardial Infarction and Thrombocytopenia: A Case Report.一名重症 COVID-19 患者合并急性心肌梗死和血小板减少症的长期体外膜肺氧合治疗（124 天）：病例报告
Infect Drug Resist. 2025 Jul 1;18:3247-3255. doi: 10.2147/IDR.S511482. eCollection 2025.
3
Long-Term Health-Related Quality of Life Following Survival of Acute Respiratory Distress Syndrome and Extracorporeal Membrane Oxygenation Due to COVID-19.新型冠状病毒肺炎所致急性呼吸窘迫综合征及体外膜肺氧合治疗存活后的长期健康相关生活质量
J Clin Med. 2025 May 12;14(10):3358. doi: 10.3390/jcm14103358.
4
Lessons Learned From Awake ECMO Approach in Covid-19-Related Acute Respiratory Distress Syndrome - a Scoping Review.从清醒体外膜肺氧合治疗新冠病毒相关急性呼吸窘迫综合征中汲取的经验教训——一项范围综述
Ther Clin Risk Manag. 2025 May 13;21:655-668. doi: 10.2147/TCRM.S507120. eCollection 2025.
5
Extracorporeal membrane oxygenation as life-saving bridge for patients with airway obstruction caused by neck and chest tumors to salvage procedure: an in-depth review.体外膜肺氧合作为颈部和胸部肿瘤引起气道阻塞患者挽救手术的救命桥梁：深入综述
Int J Surg. 2025 Jan 1;111(1):1090-1100. doi: 10.1097/JS9.0000000000002008.
6
Acute Kidney Injury, Renal Replacement Therapy, and Extracorporeal Membrane Oxygenation Treatment During the COVID-19 Pandemic: Single-Center Experience.2019年冠状病毒病大流行期间的急性肾损伤、肾脏替代治疗和体外膜肺氧合治疗：单中心经验
Medicina (Kaunas). 2025 Jan 28;61(2):237. doi: 10.3390/medicina61020237.
7
Modifying Candidacy and Management to Improve Extracorporeal Support During Supply-Demand Mismatch.调整适应症及管理措施以改善供需不匹配期间的体外支持。
Ann Thorac Surg Short Rep. 2023 Sep 28;2(1):112-116. doi: 10.1016/j.atssr.2023.09.008. eCollection 2024 Mar.
8
Multi-modal prediction of extracorporeal support-a resource intensive therapy, utilizing a large national database.利用大型国家数据库对体外支持（一种资源密集型治疗）进行多模态预测。
JAMIA Open. 2025 Jan 6;8(1):ooae158. doi: 10.1093/jamiaopen/ooae158. eCollection 2025 Feb.
9
The Influence of Prone Positioning on Energy and Protein Delivery in COVID-19 Patients Requiring ECMO Support.俯卧位对 COVID-19 患者接受 ECMO 支持时能量和蛋白质供给的影响。
Nutrients. 2024 Oct 18;16(20):3534. doi: 10.3390/nu16203534.
10
Platelet Aggregation Alterations in Patients with Severe Viral Infection Treated at the Intensive Care Unit: Implications for Mortality Risk.重症监护病房治疗的严重病毒感染患者血小板聚集的改变：对死亡风险的影响
Pathogens. 2024 Sep 10;13(9):778. doi: 10.3390/pathogens13090778.
本文引用的文献
1
COVID-19 Complicated by Acute Pulmonary Embolism.新型冠状病毒肺炎合并急性肺栓塞
Radiol Cardiothorac Imaging. 2020 Mar 16;2(2):e200067. doi: 10.1148/ryct.2020200067. eCollection 2020 Apr.
2
COVID-19 pneumonia: different respiratory treatments for different phenotypes?新冠肺炎：针对不同表型采用不同的呼吸治疗方法？
Intensive Care Med. 2020 Jun;46(6):1099-1102. doi: 10.1007/s00134-020-06033-2. Epub 2020 Apr 14.
3
Incidence of thrombotic complications in critically ill ICU patients with COVID-19.COVID-19 重症监护病房危重症患者的血栓并发症发生率。
Thromb Res. 2020 Jul;191:145-147. doi: 10.1016/j.thromres.2020.04.013. Epub 2020 Apr 10.
4
In-hospital cardiac arrest outcomes among patients with COVID-19 pneumonia in Wuhan, China.中国武汉 COVID-19 肺炎患者院内心搏骤停结局。
Resuscitation. 2020 Jun;151:18-23. doi: 10.1016/j.resuscitation.2020.04.005. Epub 2020 Apr 10.
5
Joint Society of Critical Care Medicine-Extracorporeal Life Support Organization Task Force Position Paper on the Role of the Intensivist in the Initiation and Management of Extracorporeal Membrane Oxygenation.联合危重病医学会-体外生命支持组织特别工作组关于强化治疗医师在体外膜氧合启动和管理中的作用的立场文件。
Crit Care Med. 2020 Jun;48(6):838-846. doi: 10.1097/CCM.0000000000004330.
6
Myocardial localization of coronavirus in COVID-19 cardiogenic shock.COVID-19 心原性休克中冠状病毒的心肌定位。
Eur J Heart Fail. 2020 May;22(5):911-915. doi: 10.1002/ejhf.1828. Epub 2020 Apr 11.
7
Intensive care management of coronavirus disease 2019 (COVID-19): challenges and recommendations.2019 冠状病毒病（COVID-19）的重症监护管理：挑战与建议。
Lancet Respir Med. 2020 May;8(5):506-517. doi: 10.1016/S2213-2600(20)30161-2. Epub 2020 Apr 6.
8
Coagulopathy and Antiphospholipid Antibodies in Patients with Covid-19.新型冠状病毒肺炎患者的凝血障碍与抗磷脂抗体
N Engl J Med. 2020 Apr 23;382(17):e38. doi: 10.1056/NEJMc2007575. Epub 2020 Apr 8.
9
Effectiveness of convalescent plasma therapy in severe COVID-19 patients.恢复期血浆疗法治疗重症 COVID-19 患者的疗效。
Proc Natl Acad Sci U S A. 2020 Apr 28;117(17):9490-9496. doi: 10.1073/pnas.2004168117. Epub 2020 Apr 6.
10
Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy.意大利伦巴第地区 1591 名 ICU 收治的 SARS-CoV-2 感染患者的基线特征和结局。
JAMA. 2020 Apr 28;323(16):1574-1581. doi: 10.1001/jama.2020.5394.
Zotero 插件